Socio-economic differences in cardiovascular disease risk factor prevalence in people with type 2 diabetes in Scotland: a cross-sectional study.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
08 2020
Historique:
accepted: 13 03 2020
pubmed: 20 3 2020
medline: 5 10 2021
entrez: 20 3 2020
Statut: ppublish

Résumé

To describe the association between socio-economic status and prevalence of key cardiovascular risk factors in people with type 2 diabetes in Scotland. A cross-sectional study of 264 011 people with type 2 diabetes in Scotland in 2016 identified from the population-based diabetes register. Socio-economic status was defined using quintiles of the area-based Scottish Index of Multiple Deprivation (SIMD) with quintile (Q)1 and Q5 used to identify the most- and least-deprived fifths of the population, respectively. Logistic regression models adjusted for age, sex, health board, history of cardiovascular disease and duration of diabetes were used to estimate odds ratios (ORs) for Q1 compared with Q5 for each risk factor. The mean (sd) age of the study population was 66.7 (12.8) years, 56% were men, 24% were in Q1 and 15% were in Q5. Crude prevalence in Q1/Q5 was 24%/8.8% for smoking, 62%/49% for BMI ≥ 30 kg/m Socio-economic deprivation is associated with higher prevalence of smoking, BMI ≥ 30 kg/m

Identifiants

pubmed: 32189372
doi: 10.1111/dme.14297
doi:

Substances chimiques

Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1395-1402

Subventions

Organisme : SHR was supported by a Chief Scientist Office fellowship (PDF/15/07) and is currently supported by a Diabetes Action Canada fellowship.
Pays : International
Organisme : Chief Scientist Office
ID : PDF/15/07
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

Références

Wilkins E, Wilson I, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R et al. European Cardiovascular Disease Statistics, 2017 edition. Brussels: European Heart Network, 2017.
Read SH, Fischbacher CM, Colhoun HM, Gasevic D, Kerssens JJ, McAllister DA et al. Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015. Diabetologia 2019; 62: 418-425.
Bartley M, Fitzpatrick R, Firth D, Marmot M. Social distribution of cardiovascular disease risk factors: change among men in England 1984-1993. J Epidemiol Community Health 2000; 54: 806-814.
Beauchamp A, Peeters A, Wolfe R, Turrell G, Harriss LR, Giles GG et al. Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors. J Epidemiol Community Health 2010; 64: 542-548.
Scottish Diabetes Data Group. Scottish Diabetes Survey 2017. NHS Scotland, 2017.
Jackson CA, Jones NRV, Walker JJ, Fischbacher CM, Colhoun HM, Leese GP et al. Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia 2012; 55: 2938-2945.
Brown AF. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev 2004; 26: 63-77.
Wild S, MacLeod F, McKnight J, Watt G, MacKenzie C, Ford I et al. Impact of deprivation on cardiovascular risk factors in people with diabetes: an observational study. Diabet Med 2008; 25: 194-199.
Guthrie B, Emslie-Smith A, Morris AD. Which people with type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region. Diabet Med 2009; 26: 1269-1276.
Collier A, Ghosh S, Hair M, Waugh N. Impact of socioeconomic status and gender on glycaemic control, cardiovascular risk factors and diabetes complications in type 1 and 2 diabetes: a population based analysis from a Scottish region. Diabetes Metab 2015; 41: 145-151.
Forbes LJ, Marchand C, Doran T, Peckham S. The role of the Quality and Outcomes Framework in the care of long-term conditions: a systematic review. Br J Gen Pract 2017; 67: e775-e784.
The NHS Confederation. Investing in general practice: the new General Medical Services Contract. Briefing 2003; 79: 1-6.
Roland M, Guthrie B. Quality and Outcomes Framework: what have we learnt? BMJ 2016; 354: i4060.
McLean G, Sutton M, Guthrie B. Deprivation and quality of primary care services: evidence for persistence of the inverse care law from the UK Quality and Outcomes Framework. J Epidemiol Community Health 2006; 60: 917-922.
Thorne T. How could the Quality and Outcomes Framework (QOF) do more to tackle health inequalities? Lond J Prim Care 2016; 8: 80-84.
Diabetes UK. Position statement: The Future of the Quality and Outcomes Framework in England, 2018. Available https://www.diabetes.org.uk/resources-s3/2018-08/Our%20position%20statement%20on%20the%20future%20of%20QOF%20in%20England.pdf Last accessed 2 June 2019.
Scottish Government. Introducing The Scottish Index of Multiple Deprivation 2016. Available http://www.nls.uk/scotgov/2016/9781786524171.pdf Last accessed 6 February 2019.
Scottish Government. SIMD16 Technical Notes, 2016. Available https://www2.gov.scot/Resource/0050/00504822.pdf Last accessed 2 June 2019.
Doshi T, Smalls BL, Williams JS, Wolfman TE, Egede LE. Socioeconomic status and cardiovascular risk control in adults with diabetes. Am J Med Sci 2016; 352: 36-44.
Kowitt SD, Donahue KE, Fisher EB, Mitchell M, Young LA. How is neighborhood social disorganization associated with diabetes outcomes? A multilevel investigation of glycemic control and self-reported use of acute or emergency health care services. Clin Diabetes Endocrinol 2018; 4: 19.
Houle J, Lauzier-Jobin F, Beaulieu M-D, Meunier S, Coulombe S, Côté J et al. Socioeconomic status and glycemic control in adult patients with type 2 diabetes: a mediation analysis. BMJ Open Diabetes Res Care 2016; 4: e000184.
Alramadan MJ, Magliano DJ, Almigbal TH, Batais MA, Afroz A, Alramadhan HJ et al. Glycaemic control for people with type 2 diabetes in Saudi Arabia - an urgent need for a review of management plan. BMC Endocr Disord 2018; 18: 62.
Ibáñez B, Galbete A, Goñi MJ, Forga L, Arnedo L, Aizpuru F et al. Socioeconomic inequalities in cardiometabolic control in patients with type 2 diabetes. BMC Public Health 2018; 18: 408.
Sundquist K, Chaikiat Å, León VR, Johansson S-E, Sundquist J. Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres. Diabetes Metab Res Rev 2011; 27: 244-254.
Tao X, Li J, Zhu X, Zhao B, Sun J, Ji L et al. Association between socioeconomic status and metabolic control and diabetes complications: a cross-sectional nationwide study in Chinese adults with type 2 diabetes mellitus. Cardiovasc Diabetol 2016; 15: 61.
Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q 2005; 83: 731-757.
Adams J, White M. Removing the health domain from the Index of Multiple Deprivation 2004-effect on measured inequalities in census measure of health. J Public Health 2006; 28: 379-383.
McGurnaghan S, Blackbourn LAK, Mocevic E, Haagen Panton U, McCrimmon RJ, Sattar N et al. Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis. Diabet Med 2019; 36: 718-725.
Scottish Government. Scottish Health Survey 2008. Edinburgh: Scottish Government, 2009. Available https://www.gov.scot/publications/scottish-health-survey-2008/ Last accessed 18 April 2019.
Scottish Government. Scottish Health Survey 2016. Edinburgh: Scottish Government, 2017. Available https://www.gov.scot/publications/scottish-health-survey-2016-volume-1-main-report/ Last accessed 18 April 2019.

Auteurs

E Whittaker (E)

Edinburgh Medical School, Edinburgh, UK.

S H Read (SH)

Centre for Population Health Sciences, Edinburgh, UK.
Women's College Research Institute, Women's College Hospital, Toronto, Canada.

H M Colhoun (HM)

Institute of Genetics and Molecular Medicine, Edinburgh, UK.

R S Lindsay (RS)

BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

S McGurnaghan (S)

Institute of Genetics and Molecular Medicine, Edinburgh, UK.

J A McKnight (JA)

Western General Hospital, University of Edinburgh, Edinburgh, UK.

N Sattar (N)

BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

S H Wild (SH)

Centre for Population Health Sciences, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH